AT-7519 is an orally bioavailable small molecule CDK inhibitor with potential antineoplastic activity
Molecular Structure:
To inquire quotation and lead time or to ask questions, please send email to info@PBpharm.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.